Valve in Valve (ViV) for bioprosthetic aortic
valve failure.
Transcatheter Aortic Valve Impantation
K. Toutouzas
Ass. Professor of Cardiology
Athens Medical School, Hippokration Hospital
MANAGEMENT OF PROSTHETIC VALVE DYSFUNCTION
23 mm EVOLUT-R Aortic ViV in regurgitant
Mosaic bioprosthesis
23 mm EVOLUT-R Aortic ViV in regurgitant
Mosaic bioprosthesis
23 mm EVOLUT-R Aortic ViV in regurgitant
Mosaic bioprosthesis
23 mm EVOLUT-R Aortic ViV in regurgitant
Mosaic bioprosthesis
Conclusions
• TAVI should be considered for VIV
• We need extensive preoperation assessment
• The surgical procedure and device plays important role
• Stenosis has worse outcome
• The hemodynamic results are inferior to TAVI in native valves